Clinical trial
An Efficacy and Safety Study of Long-Term Risperidone Microspheres in…
NCT00269919 · Janssen Korea, Ltd., Korea, Industry · Completed
Key facts
| NCT number | NCT00269919 |
|---|---|
| Title | An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia |
| Official title | Effect on Efficacy, Safety and Quality of Life by Long-Term Treatment of Long-Acting Risperidone Microspheres in Patients With Schizophrenia |
| Lead sponsor | Janssen Korea, Ltd., Korea, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Risperidone Long-Acting Injectable (RLAI) |
| Enrollment | 40 |
| Start date | Aug 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Dec 26, 2005 |
| Last update posted | Apr 16, 2014 |
| Countries | South Korea |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: